Atossa Genetics, Inc. (NASDAQ:ATOS) reported the earnings of $-0.1/Share in the last quarter where the estimated EPS by analysts was $-0.11/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 9.1%.
Some buy side analysts are also providing their Analysis on Atossa Genetics, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 1 Analysts reported that the Price Target for Atossa Genetics, Inc. might touch $1.75 high while the Average Price Target and Low price Target is $26.25 and $1.75 respectively.
Atossa Genetics, Inc. closed its last trading session at $1.94 with the gain of 10.82%. The Market Capitalization of the company stands at 8.17 Million. The Company has 52-week high of $10.65 and 52-week low of $1.5. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 21.3% where SMA50 and SMA200 are 15.39% and -44.17% respectively. The Company Touched its 52-Week High on Feb 17, 2016 and 52-Week Low on Oct 28, 2016.
The Relative Volume of the company is 15.3 and Average Volume (3 months) is 97.49 million. Atossa Genetics, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 0%.
While looking at the Stock’s Performance, Atossa Genetics, Inc. currently shows a Weekly Performance of 15.59%, where Monthly Performance is 41.45%, Quarterly performance is -37.68%, 6 Months performance is -57.84% and yearly performance percentage is -71.33%. Year to Date performance value (YTD perf) value is -55.21%. The Stock currently has a Weekly Volatility of 17.55% and Monthly Volatility of 15.49%.